Latest filing published 04 Apr 2007 for Ligand Pharmaceuticals INC, €2,621.
Insider track record
No signal scores available.
Henry F. Blissenbach: trading record in brief
All filings by Henry F. Blissenbach on record concern Ligand Pharmaceuticals Inc. We count 6 filings, every one of them for a trade on 2 April 2007.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 4 April 2007: an option exercise of €2,621, in Ligand Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Henry F. Blissenbach
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 756 shares@ US$4.62Common StockSEC:0000886163-07-000067:0
- 763 shares@ US$4.58Common StockSEC:0000886163-07-000067:1
- 857 shares@ US$5.68Common StockSEC:0000886163-07-000067:2
- 4,113 shares@ US$1.82Common StockSEC:0000886163-07-000067:3
- 1,507 shares@ US$4.98Common StockSEC:0000886163-07-000067:4
- 2,009 shares@ US$3.73Common StockSEC:0000886163-07-000067:5
6 of 6 declarations
